Literature DB >> 11259476

Cellular defenses against excitotoxic insults.

R M Sapolsky1.   

Abstract

The cellular events mediating necrotic neuron death are now reasonably well understood, and involve excessive extracellular accumulation of glutamate and free cytosolic calcium. When such necrotic neurological insults occur, neurons are not passively buffeted, but instead mobilize a variety of defenses in an attempt to decrease the likelihood of neuron death, or to decrease the harm to neighboring neurons (by decreasing the likelihood of inflammation). This review considers some of these defenses, organizing them along the lines of those which decrease neuronal excitability, decrease extracellular glutamate accumulation, decrease cytosolic calcium mobilization, decrease calcium-dependent degenerative events, enhance neuronal energetics, and bias a neuron towards apoptotic, rather than necrotic, death. Although these are currently perceived as a disparate array of cellular adaptations, some experimental approaches are suggested that may help form a more unified subdiscipline of cellular defenses against neurological insults. Such an advance would help pave the way for the rational design of therapeutic interventions against necrotic insults.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259476     DOI: 10.1046/j.1471-4159.2001.00203.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Neuroprotective effect of GMP in hippocampal slices submitted to an in vitro model of ischemia.

Authors:  Ivaldo J L Oliveira; Simone Molz; Diogo O Souza; Carla I Tasca
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

Review 2.  Neurogenic neuroprotection.

Authors:  Eugene V Golanov; Ping Zhou
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

3.  Rapid dopaminergic and GABAergic modulation of calcium and voltage transients in dendrites of prefrontal cortex pyramidal neurons.

Authors:  Wen-Liang Zhou; Srdjan D Antic
Journal:  J Physiol       Date:  2012-05-28       Impact factor: 5.182

4.  Functional reduction of SK3-mediated currents precedes AMPA-receptor-mediated excitotoxicity in dopaminergic neurons.

Authors:  Bruno A Benítez; Helen M Belálcazar; Agustín Anastasía; Daniel T Mamah; Charles F Zorumski; Daniel H Mascó; Daniel G Herrera; Gabriel A de Erausquin
Journal:  Neuropharmacology       Date:  2010-10-31       Impact factor: 5.250

5.  Presynaptic silencing is an endogenous neuroprotectant during excitotoxic insults.

Authors:  Joshua Hogins; Devon C Crawford; Xiaoping Jiang; Steven Mennerick
Journal:  Neurobiol Dis       Date:  2011-05-14       Impact factor: 5.996

6.  Roles of 5-HT on phase transition of neurite outgrowth in the identified serotoninergic neuron C1, Helisoma trivolvis.

Authors:  Kee-Chan Ahn; Glen B Baker; Won-Cheoul Jang; Hyeon-Cheol Cha; Myung Jin Moon; Mee-Sook Song
Journal:  Invert Neurosci       Date:  2018-08-20

7.  Increased expression of alpha 1A Ca2+ channel currents arising from expanded trinucleotide repeats in spinocerebellar ataxia type 6.

Authors:  E S Piedras-Renteria; K Watase; N Harata; O Zhuchenko; H Y Zoghbi; C C Lee; R W Tsien
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

8.  Firing pattern modulation through SK channel current increase underlies neuronal survival in an organotypic slice model of Parkinson's disease.

Authors:  Yuan Wang; Liang Qu; Xue-Lian Wang; Li Gao; Zhen-Zhen Li; Guo-Dong Gao; Qian Yang
Journal:  Mol Neurobiol       Date:  2014-05-20       Impact factor: 5.590

Review 9.  Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia.

Authors:  Ramendra N Saha; Kalipada Pahan
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

10.  Vulnerability to stroke: implications of perinatal programming of the hypothalamic-pituitary-adrenal axis.

Authors:  Tara K S Craft; A Courtney Devries
Journal:  Front Behav Neurosci       Date:  2009-12-09       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.